Its operating margin is a fraction of the market's while its net margin sits above the market's, which is where the earnings comparison stops being about the business. UiPath (PATH) stock has climbed 52.4% over the trailing three months against 4.6% for the S&P 500, and trades at about $15.30 a share. On earnings it looks unremarkable, at 24.4 times against 23.8 for the market.
That is the least informative comparison here. Its Earnings Multiple Is Not Measuring Its Operations UiPath runs a 6.0% operating margin against 18.4% for the S&P 500, and yet reports a net margin of 19.6% against the market's 13.1%. Earnings that large do not come out of an operating line that thin: the gap opens up below the operating line, and that is why the earnings multiple looks ordinary.
Priced on sales, the premium is plain at 4.8 times against 3.3 for the index, on $1.7 billion of revenue over the trailing twelve months. On operating cash flow the premium is narrower, at 20.8 times against 15.6 for the index. The Sales Premium Is A Bet On Process Orchestration What the company sells has changed.
It grew up on deterministic robots that repeat one task the same way every time; what it leads with now is process orchestration, software that sequences agents, automations, systems and people through a whole workflow. Maestro Case, in public preview, pushes that into exception-heavy work with no fixed path, and its UiPath for coding agents product targets what management says nearly every customer conversation surfaces: an automation backlog growing faster than customers can build and maintain. Revenue has grown at an average annual rate of 15.1% over the last three years against 5.9% for the S&P 500.
Growth alongside margins earned in the operation is one of the things the Trefis High Quality Portfolio insists on in its holdings, and it is the second half of that pairing that is still missing here. Its Recurring Base Is Compounding Slower Than Its Revenue The counter is in the recurring line. Annual recurring revenue reached $1.901 billion in fiscal Q1 2027, up 12% year over year, while reported revenue grew 17.3%, and ARR rather than the reported line is the rate a subscription platform actually compounds at.
Management's answer is that on a trailing twelve-month basis revenue growth is 15% against ARR's 12%. Asked to size the ARR coming from the AI products the case rests on, management said only that it would disclose product ARR periodically. The downside record is part of the counter: the stock fell 75% during the 2022 inflation shock against a 24% drop for the S&P 500, and remains about 65% below its pre-crisis high.
Extract — continue reading at the source.
